Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 6:28 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1945–1968 of 3,255 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Device Clear all

Conditions: Mild Cognitive Impairment, Cognitive Impairment
Interventions: Insulin, Placebo, intranasal nebulizer-like device; Drug · Other · Device
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 55 Years to 85 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Wound Heal
Interventions: MAP Wound Matrix, DuoDerm; Device
Lead sponsor: Tempo Therapeutics; Industry
Eligibility: 22 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 3
States / cities: Encino, California • Indianapolis, Indiana • Cypress, Texas

Conditions: Breast Cancer
Interventions: Mammography; Radiation
Lead sponsor: Lunit Inc.; Industry
Eligibility: Female only
Enrollment: 240 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Glaucoma, Retinal Disease, Corneal Disease
Interventions: Not listed
Lead sponsor: Nidek Co. LTD.; Industry
Eligibility: 18 Years and older
Enrollment: 89 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Atrial Fibrillation, Arrythmia
Interventions: Impulse Dynamics Optimizer Device; Device
Lead sponsor: Hackensack Meridian Health; Other
Eligibility: 18 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 1
States / cities: Hackensack, New Jersey

Conditions: Central Line Complication, Central Line Infection, Central Line-Associated Infection, Central Line Sepsis, Short Gut Syndrome, Quality of Life, Pediatric Disorder
Interventions: Wearable Central Line Securement Device (Vest), Traditional Securement Dressing; Device · Other
Lead sponsor: Ryan St. Pierre-Hetz; Other
Eligibility: 0 Years to 18 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Congestive Heart Failure
Interventions: Nitric Oxide, Nitrogen; Drug
Lead sponsor: Mallinckrodt; Industry
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2008
U.S. locations: 8
States / cities: Newark, New Jersey • Durham, North Carolina • Cincinnati, Ohio + 4 more

Conditions: Rheumatoid Arthritis
Interventions: Active Stimulation, Sham Stimulation, Baricitinib, Background Treatment; Device · Drug
Lead sponsor: Galvani Bioelectronics; Industry
Eligibility: 22 Years to 75 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2032
U.S. locations: 12
States / cities: Anniston, Alabama • Covina, California • Whittier, California + 8 more

Conditions: Telemedicine, Gait, Hemiplegic, Gait Disorders, Neurologic, Stroke, Orthotic Devices, Gait Analysis
Interventions: Delivery of iStride™ device gait treatment using telemedicine; Device
Lead sponsor: Moterum Technologies, Inc.; Industry
Eligibility: 21 Years to 80 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Basal Cell Carcinoma
Interventions: Reflectance ConfocaL Microscopy And Optical Coherence Tomography Guided, Radiation Therapy; Device · Radiation
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 7
States / cities: Basking Ridge, New Jersey • Middletown, New Jersey • Montvale, New Jersey + 4 more

Conditions: Postpartum Hemorrhage, Immediate Postpartum Hemorrhage, Hemorrhage, Postpartum
Interventions: KOKO Device; Device
Lead sponsor: KOKO Medical Inc.; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 73 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 17
States / cities: Birmingham, Alabama • Newark, Delaware • Miami, Florida + 12 more

Conditions: Postpartum, Intrauterine Devices, Copper
Interventions: No intervention - observational study only; Other
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older · Female only
Enrollment: 309 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Thoracoabdominal Aortic Aneurysm
Interventions: Visceral Manifold and Thoracic Bifurcation, Unitary Manifold, TAAA Debranching Stent Graft System; Device
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Heart Failure
Interventions: Quartet 1457Q LV Lead; Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 499 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 30
States / cities: Huntsville, Alabama • Phoenix, Arizona • Jonesboro, Arkansas + 26 more

Conditions: Pelvic Pain
Interventions: ApexM, Sham Device; Device
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older · Female only
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Skin Cancer, Signs and Symptoms
Interventions: Modulated Imaging (MI), Photodynamic therapy; Device · Other
Lead sponsor: University of California, Irvine; Other
Eligibility: 18 Years and older
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 1
States / cities: Irvine, California

Conditions: Complex Aortic Aneurysms, Thoracoabdominal Aneurysms, Pararenal Aneurysms, Juxtarenal Aneurysms, Marfan Syndrome, Ehlers-Danlos Syndrome, Loeys-Dietz Syndrome, Aortic Arch Aneurysm
Interventions: Custom Made Fenestrated or Branched Stent Graft; Device
Lead sponsor: Andres Schanzer; Other
Eligibility: 18 Years and older
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2030
U.S. locations: 1
States / cities: Worcester, Massachusetts

Conditions: Influenza Viral Infections
Interventions: Influenza A/Texas/71/2017 (H3N2), Sham placebo; Biological
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 46 Years
Enrollment: 33 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Pancreatic Cancer
Interventions: Gemcitabine, local delivery; Drug
Lead sponsor: RenovoRx; Industry
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 2
States / cities: Mountain View, California • Tampa, Florida

Conditions: Occipital Neuralgia
Interventions: Device: Cryo-Touch III Study treatment at Day 0.; Device
Lead sponsor: Pacira Pharmaceuticals, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 3
States / cities: Napa, California • Boise, Idaho • Overland Park, Kansas

Conditions: Atrial Fibrillation (AF), Stroke
Interventions: WATCHMAN Elite LAAC Device; Device
Lead sponsor: Boston Scientific Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2032
U.S. locations: 2
States / cities: Jonesboro, Arkansas • Charlotte, North Carolina

Conditions: Grade 1 Endometrial Endometrioid Carcinoma, Endometrial Intraepithelial Neoplasia, Metabolic Comorbidities
Interventions: Tirzepatide; Drug
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: COPD
Interventions: Breath Responsive Variable Bolus Oxygen Conserving Device; Device
Lead sponsor: StratiHealth; Industry
Eligibility: 65 Years to 85 Years
Enrollment: 35 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 3
States / cities: Oceanside, California • Vista, California • Westminster, California

Conditions: Non-inflammatory Degenerative Joint Disease, Osteoarthritis, Avascular Necrosis, Post-Traumatic Osteoarthritis of Hip
Interventions: Not listed
Lead sponsor: DePuy Orthopaedics; Industry
Eligibility: 20 Years to 75 Years
Enrollment: 81 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 5
States / cities: Sacramento, California • Denver, Colorado • Winston-Salem, North Carolina + 2 more

Search by objective public record fields.

Study of Nasal Insulin to Fight Forgetfulness - Device Study

Safety of Microporous Annealed Particle (MAP) Wound Matrix in Patients With Clean Surgical Wounds.

Study to Evaluate Effectiveness of Investigational Device in the Assistance of Detection and Diagnosis of Breast Cancer

Nidek RS3000 Comparative Study

Arrythmia Burden in Cardiac Contractility Modulation (CCM)

Innovative Central Line Securement Device in the Pediatric Population

The Effects of Nitric Oxide for Inhalation During Left Ventricular Assists Device (LVAD) Implantation

ConsideRAte Study - Splenic Stimulation for RA

Treatment of Hemiparetic Gait Impairments Using Telehealth With the Moterum iStride Solution™

A Study on Radiation Therapy Guided by the Reflectance Confocal Microscopy (RCM)/Optical Coherence Tomography (OCT) Device in People With Basal Cell Carcinoma

Safety and Effectiveness of the KOKO Device to Treat Primary Abnormal Postpartum Uterine Bleeding or Hemorrhage

Expulsion of Immediate Postplacental Copper Intrauterine Devices at Six Months: A Prospective Cohort Study

Safety, Efficacy, Longitudinal Costs and Patient-Centered Outcomes Using a TAAA Debranching Device

Quartet 1457Q Left Ventricular (LV) Lead Investigational Device Exemption (IDE) Study

Intra-vaginal Electrical Stimulation Device Compared to Sham Device for Chronic Pelvic Pain

Optimizing Photodynamic Therapy of Cutaneous Neoplastic Diseases Via Structured Illumination and Real-time Dosimetry.

Complex Aortic Aneurysm Repair Using Physician Modified Endografts and Custom Made Devices

Single Dose Texas 2017 (H3N2) Challenge Study

A Dose Escalation Safety Study of Locally-Delivered Gemcitabine in Pancreatic Cancer

Study Evaluating the Treatment of Occipital Neuralgia

Elite AF IDE Trial (Elite AF)

Tirzepatide and Levonorgestrel IUD Therapy for EIN and Early-Stage Endometrial Cancer

A Prospective Observational Study of the Breath Responsive Variable Bolus Oxygen Conserving Device

Ceramic On Ceramic (COC) 36mm PAS IDE Rollover Subjects; Ceramic Acetabular Bearing With Ceramic Femoral Head in Total Hip Replacement